142 related articles for article (PubMed ID: 18500432)
1. Outcome of high titer antinuclear antibody positivity in individuals without connective tissue disease: a 10-year follow-up.
Wijeyesinghe U; Russell AS
Clin Rheumatol; 2008 Nov; 27(11):1399-402. PubMed ID: 18500432
[TBL] [Abstract][Full Text] [Related]
2. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
Myckatyn SO; Russell AS
J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon.
Wollersheim H; Thien T; Hoet MH; Van Venrooy WJ
Eur J Clin Invest; 1989 Dec; 19(6):535-41. PubMed ID: 2515974
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura.
Altintas A; Ozel A; Okur N; Okur N; Cil T; Pasa S; Ayyildiz O
J Thromb Thrombolysis; 2007 Oct; 24(2):163-8. PubMed ID: 17436144
[TBL] [Abstract][Full Text] [Related]
5. Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years.
Selmi C; Ceribelli A; Generali E; Scirè CA; Alborghetti F; Colloredo G; Porrati L; Achenza MI; De Santis M; Cavaciocchi F; Massarotti M; Isailovic N; Paleari V; Invernizzi P; Matthias T; Zucchi A; Meroni PL
Autoimmun Rev; 2016 Feb; 15(2):162-6. PubMed ID: 26524640
[TBL] [Abstract][Full Text] [Related]
6. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
[TBL] [Abstract][Full Text] [Related]
7. Antinuclear antibodies in interstitial lung disease: Prevalence and clinical significance.
Ghrairi N; Aouadi S; Elhechmi YZ; Ben Saad S; Ben Ali I; Yalaoui S
Tunis Med; 2019 Nov; 97(11):1240-1245. PubMed ID: 32173825
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of determination of DFS70 antibodies to rule out connective tissue diseases].
Kiefer D; von Brunn M; Baraliakos X; Andreica I; Braun J
Z Rheumatol; 2020 Oct; 79(8):749-754. PubMed ID: 31889213
[TBL] [Abstract][Full Text] [Related]
9. Anti-nuclear antibodies as predictor of outcome in a multi-center cohort of Italian children and adolescents with Raynaud's phenomenon.
Falcini F; Rigante D; Candelli M; Martini G; Corona F; Petaccia A; La Torre F; Raffaele CG; Matucci Cerinic M
Clin Rheumatol; 2015 Jan; 34(1):167-9. PubMed ID: 25428518
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of 39 patients with antibodies to extractable nuclear antigens despite negative antinuclear antibodies: evidence for autoimmunity including neurologic and connective tissue diseases.
Davis JM; Moder KG; Homburger HA; Ytterberg SR
Medicine (Baltimore); 2005 Jul; 84(4):208-217. PubMed ID: 16010205
[TBL] [Abstract][Full Text] [Related]
11. Undifferentiated connective tissue disease: predictors of evolution into definite disease.
García-González M; Rodríguez-Lozano B; Bustabad S; Ferraz-Amaro I
Clin Exp Rheumatol; 2017; 35(5):739-745. PubMed ID: 28770704
[TBL] [Abstract][Full Text] [Related]
12. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).
Bodolay E; Csiki Z; Szekanecz Z; Ben T; Kiss E; Zeher M; Szücs G; Dankó K; Szegedi G
Clin Exp Rheumatol; 2003; 21(3):313-20. PubMed ID: 12846049
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic.
Vlachoyiannopoulos PG; Tzavara V; Dafni U; Spanos E; Moutsopoulos HM
J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885
[TBL] [Abstract][Full Text] [Related]
14. Lung-dominant connective tissue disease among patients with interstitial lung disease: prevalence, functional stability, and common extrathoracic features.
Pereira DA; Dias OM; Almeida GE; Araujo MS; Kawano-Dourado LB; Baldi BG; Kairalla RA; Carvalho CR
J Bras Pneumol; 2015; 41(2):151-60. PubMed ID: 25972968
[TBL] [Abstract][Full Text] [Related]
15. Clinical use of anti-DFS70 autoantibodies.
Kang SY; Lee WI; Kim MH; La Jeon Y
Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541
[TBL] [Abstract][Full Text] [Related]
16. Measurement of antinuclear antibodies and their fine specificities: time for a change in strategy?
Otten HG; Brummelhuis WJ; Fritsch-Stork R; Leavis HL; Wisse BW; van Laar JM; Derksen RHWM
Clin Exp Rheumatol; 2017; 35(3):462-470. PubMed ID: 28240588
[TBL] [Abstract][Full Text] [Related]
17. Screening for connective tissue disease in pulmonary arterial hypertension.
Pagán RJ; Lee AS; Austin CO; Burger CD
South Med J; 2014 Oct; 107(10):666-9. PubMed ID: 25279875
[TBL] [Abstract][Full Text] [Related]
18. [Standardized diagnosis and treatment of undifferentiated connective tissue disease and mixed connective tissue disease].
Mo YQ; Yan Q; Ye S; Dai L; Zhao Y
Zhonghua Nei Ke Za Zhi; 2022 Oct; 61(10):1119-1127. PubMed ID: 36207966
[TBL] [Abstract][Full Text] [Related]
19. The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2-4 years' follow-up.
Al-Allaf AW; Ottewell L; Pullar T
Clin Rheumatol; 2002 Nov; 21(6):472-7. PubMed ID: 12447630
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic significance of antinuclear antibodies].
Swaak AJ
Ned Tijdschr Geneeskd; 2000 Mar; 144(13):585-9. PubMed ID: 10761543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]